We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.22B
AUM Growth
+$375M
Cap. Flow
+$293M
Cap. Flow %
13.2%
Top 10 Hldgs %
17.55%
Holding
845
New
119
Increased
485
Reduced
177
Closed
64

Top Buys

Rank Stock Value
1
NOVT icon
Novanta
NOVT
+$18.9M
2
IRBT
iRobot
IRBT
+$18.1M
3
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$18M
4
OII icon
Oceaneering
OII
+$17M
5
DDD icon
3D Systems Corp
DDD
+$10.3M

Top Sells

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$14.9M
2
FTI icon
TechnipFMC
FTI
+$13.5M
3
ARAY icon
Accuray
ARAY
+$10.8M
4
IMMR icon
Immersion
IMMR
+$8.19M
5
XONE
The ExOne Company
XONE
+$4.9M

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Industrials 13.74%
3 Healthcare 10.47%
4 Consumer Discretionary 8.12%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHO
301
DELISTED
LaSalle Hotel Properties
LHO
$1.69M 0.08%
60,179
+9,622
+19% +$276K
STE icon
302
Steris
STE
$22.6B
$1.68M 0.08%
19,257
+8,490
+79% +$757K
ODP
303
DELISTED
ODP
ODP
$1.64M 0.07%
46,409
+2,836
+7% +$98.2K
NFLX icon
304
Netflix
NFLX
$307B
$1.63M 0.07%
84,740
-5,560
-6% -$107K
DG icon
305
Dollar General
DG
$28.1B
$1.62M 0.07%
17,429
-1,326
-7% -$114K
CLX icon
306
Clorox
CLX
$12.8B
$1.62M 0.07%
10,889
-310
-3% -$42.2K
MTN icon
307
Vail Resorts
MTN
$5.23B
$1.61M 0.07%
7,573
+2,632
+53% +$589K
PVLA
308
Palvella Therapeutics
PVLA
$2.23B
$1.59M 0.07%
+2,632
New +$1.22M
NKTR icon
309
Nektar Therapeutics
NKTR
$2.48B
$1.56M 0.07%
+1,423
New +$842K
ATRA icon
310
Atara Biotherapeutics
ATRA
$74.3M
$1.55M 0.07%
3,432
-305
-8% -$113K
KDP icon
311
Keurig Dr Pepper
KDP
$41.3B
$1.54M 0.07%
15,888
+354
+2% +$31.8K
MCD icon
312
McDonald's
MCD
$196B
$1.52M 0.07%
8,817
+531
+6% +$89.2K
PEP icon
313
PepsiCo
PEP
$189B
$1.52M 0.07%
12,656
+860
+7% +$98.2K
PFE icon
314
Pfizer
PFE
$149B
$1.49M 0.07%
43,240
+4,325
+11% +$147K
TWTR
315
DELISTED
Twitter, Inc.
TWTR
$1.48M 0.07%
61,429
-31,706
-34% -$651K
GCI
316
DELISTED
Gannett Co., Inc
GCI
$1.47M 0.07%
126,694
-1,173
-0.9% -$12.3K
IBM icon
317
IBM
IBM
$220B
$1.44M 0.07%
9,846
+271
+3% +$39.4K
JUNO
318
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.43M 0.06%
25,207
-23,354
-48% -$1.16M
STZ icon
319
Constellation Brands
STZ
$22.6B
$1.42M 0.06%
6,191
-1,844
-23% -$399K
PRGO icon
320
Perrigo
PRGO
$1.74B
$1.41M 0.06%
16,196
-2,258
-12% -$194K
MSFT icon
321
Microsoft
MSFT
$3.71T
$1.4M 0.06%
16,372
-476
-3% -$39K
BLUE
322
DELISTED
bluebird bio
BLUE
$1.39M 0.06%
478
-353
-42% -$717K
JKHY icon
323
Jack Henry & Associates
JKHY
$11.2B
$1.38M 0.06%
11,829
+3,784
+47% +$423K
CYH icon
324
Community Health Systems
CYH
$416M
$1.38M 0.06%
322,688
+19,712
+7% +$99.1K
ACGN
325
DELISTED
Aceragen Inc
ACGN
$1.35M 0.06%
+4,713
New +$1.35M
11 12
13
14 15

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q4 2017 Portfolio in Review

As of Q4 2017, Vident Investment Advisory held 845 positions worth $2.22B, up 20% from $1.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Vident Investment Advisory deployed $293M of net new capital in Q4 2017, opening 119 new positions and adding to 485 existing holdings. Its largest new stake was Novanta: 388,786 shares worth $19.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Northrop Grumman, an estimated $14.9M trimmed.

  • Vident Investment Advisory's largest Q4 2017 buy was Novanta: 388,786 shares worth $19.4M.
  • Vident Investment Advisory added most to iRobot in Q4 2017, an estimated $18.1M increase.
  • Vident Investment Advisory's biggest Q4 2017 reduction was Northrop Grumman, cutting an estimated $14.9M.
  • Vident Investment Advisory fully exited TechnipFMC in Q4 2017, selling an estimated $13.5M.
  • Vident Investment Advisory's ten largest holdings make up 18% of its $2.22B portfolio in Q4 2017.
  • Vident Investment Advisory opened 119 new positions and closed 64 in Q4 2017.
  • Vident Investment Advisory's portfolio value rose 20% quarter-over-quarter to $2.22B.

Based on Vident Investment Advisory's 13F filing for Q4 2017, filed 15 Feb 2018.